139 related articles for article (PubMed ID: 832904)
21. The effect of replacement of L-alanine residue by glycine, L-serine or D-alanine in an N-acetylmuramyl-L-alanyl-D-isoglutamine on immunoadjuvancies of molecules.
Kotani S; Watanabe Y; Kinoshita F; Morisaki I; Kato K
Biken J; 1977 Jun; 20(2):39-45. PubMed ID: 588232
[TBL] [Abstract][Full Text] [Related]
22. Kinetics of the humoral and cellular immune response of guinea pigs after injection of the synthetic adjuvant N-acetylmuramyl L-alanyl-D-isoglutamine: comparison with Freund complete adjuvant.
Souvannavong V; Adam A; Lederer E
Infect Immun; 1978 Mar; 19(3):966-71. PubMed ID: 346491
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of macrophage migration by muramyl peptides.
Nagao S; Tanaka A; Yamamoto Y; Koga T; Onoue K; Shiba T; Kusumoto K; Kotani S
Infect Immun; 1979 May; 24(2):308-12. PubMed ID: 457276
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and immunoadjuvant activities of muramoyl-L-alanyl-D-isoglutamine and some carbohydrate analogs.
Kiso M; Kaneda Y; Okumura H; Hasegawa A; Azuma I; Yamamura Y
Carbohydr Res; 1980 Feb; 79(1):C17-9. PubMed ID: 7357566
[No Abstract] [Full Text] [Related]
25. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.
Carelli C; Audibert F; Chedid L
Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069
[TBL] [Abstract][Full Text] [Related]
26. [A comparative study of the immunological properties of peptidoglycans of different origins].
Zakharova NS; Shepeleva IB; Kalina NG; Britsina MV; Elkina SI; Andronova TM; Ermolova EV
Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):52-5. PubMed ID: 1858472
[TBL] [Abstract][Full Text] [Related]
27. New model of a synthetic adjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine- induced arthritis: clinical and histologic studies in athymic nude and euthymic rats.
Kohashi O; Aihara K; Ozawa A; Kotani S; Azuma I
Lab Invest; 1982 Jul; 47(1):27-36. PubMed ID: 7087395
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs.
Saiki I; Tanio Y; Yamawaki M; Uemiya M; Kobayashi S; Fukuda T; Yukimasa H; Yamamura Y; Azuma I
Infect Immun; 1981 Jan; 31(1):114-21. PubMed ID: 6971259
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant activity of 6-amino-6-deoxy-muramyldipeptides and their acylamino derivatives on the induction of delayed hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.
Azuma I; Okumura H; Saiki I; Tanio Y; Kiso M; Hasegawa A; Yamamura Y
Infect Immun; 1981 Jun; 32(3):1305-8. PubMed ID: 7251169
[TBL] [Abstract][Full Text] [Related]
30. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Mozes E; Sela M; Chedid L
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of carbohydrate analogs (positional, configurational, and optical) of n-acetylmuramoyl-L-alanyl-D-isoglutamine, and their immunoadjuvant activities.
Hasegawa A; Kaneda Y; Goh Y; Nishibori K; Kiso M; Azuma I
Carbohydr Res; 1981 Aug; 94(2):143-63. PubMed ID: 7273036
[TBL] [Abstract][Full Text] [Related]
32. Immunoadjuvant activities of peptidoglycan subunits from the cell walls of Staphyloccus aureus and Lactobacillus plantarum.
Kotani S; Watanabe Y; Shimono T; Kinoshita F; Narita T
Biken J; 1975 Jun; 18(2):93-103. PubMed ID: 1180873
[TBL] [Abstract][Full Text] [Related]
33. The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: evidence of initial target cells for the adjuvant activity.
Sugimura K; Uemiya M; Saiki I; Azuma I; Yamamura Y
Cell Immunol; 1979 Mar; 43(1):137-49. PubMed ID: 313841
[No Abstract] [Full Text] [Related]
34. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
Adam A; Souvannavong V; Lederer E
Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370
[No Abstract] [Full Text] [Related]
35. Adjuvant activity of nocardomycoloyl derivatives of N-acetylmuramyldipeptide in mice and guinea pigs.
Saiki I; Uemiya M; Kusama T; Yamamura Y; Azuma I
Microbiol Immunol; 1980; 24(3):265-9. PubMed ID: 6968020
[No Abstract] [Full Text] [Related]
36. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
37. The immunomodulatory property of a novel synthetic compound adamantylamide dipeptide.
Masek K; Seifert J; Flegel M; Krojidlo M; Kolínsky J
Methods Find Exp Clin Pharmacol; 1984 Nov; 6(11):667-9. PubMed ID: 6530904
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds.
Azuma I; Sugimura K; Taniyama T; Yamawaki M; Yamamura Y
Infect Immun; 1976 Jul; 14(1):18-27. PubMed ID: 820642
[TBL] [Abstract][Full Text] [Related]
39. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
[TBL] [Abstract][Full Text] [Related]
40. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
